About Wockhardt Regenerative Pvt. ltd.
Wockhardt Regenerative Private Limited is a specialized Regenerative Solution Company operating under the umbrella of the global healthcare and pharmaceutical enterprise, the Wockhardt Group. Incorporated on December 26, 2020, the company focuses on advanced regenerative tools and regulated medical devices designed to support restorative healthcare applications. Our medical devices are manufactured under an ISO 13485:2016 certified Quality Management System and in accordance with a valid manufacturing license (MFG/MD/2023/000288) issued by the Regulatory Authority of India.
VISION
To be a globally trusted leader in regenerative medicine, transforming healthcare through innovative biological solutions that restore, rejuvenate, and improve quality of life.
MISSION
At Wockhardt Regenerative, we harness cutting-edge science, innovation, and quality-driven processes to develop advanced regenerative solutions that address unmet medical needs. Through unwavering commitment to safety, compliance, research excellence, and customer-centricity, we strive to improve patient outcomes while setting new benchmarks in regenerative medicine.
Generic Name:
• Wockhardt’s Autologous Platelet Growth Factor Concentrate (GFC) Kit
• Wockhardt’s Autologous Platelet Growth Factor Concentrate (GFC) Kit to Further Isolate Exosomes
Class of Medical Device:
Class A
Shelf life:
24 Months
Sterile or Non Sterile:
Sterilized
License No:
MFG/MD/2023/000288